Liaw YF - Search Results

1

Acute hepatitis delta virus superinfection in patients with liver cirrhosis.

Liaw YF, Chen TJ, Chu CM, Lin HH. Liaw YF, et al. J Hepatol. 1990 Jan;10(1):41-5. doi: 10.1016/0168-8278(90)90071-x. J Hepatol. 1990. PMID: 2307829

2

Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection.

Chu CM, Lin CC, Chen YC, Jeng WJ, Lin SM, Liaw YF. Chu CM, et al. Among authors: liaw yf. Br J Cancer. 2012 Dec 4;107(12):2010-5. doi: 10.1038/bjc.2012.474. Epub 2012 Oct 18. Br J Cancer. 2012. PMID: 23079574 Free PMC article.

3

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.

Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. Liaw YF, et al. Hepatology. 1999 Aug;30(2):567-72. doi: 10.1002/hep.510300221. Hepatology. 1999. PMID: 10421670 Clinical Trial.

4

Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus.

Chu CM, Yeh CT, Liaw YF. Chu CM, et al. Among authors: liaw yf. Gut. 1999 Oct;45(4):613-7. doi: 10.1136/gut.45.4.613. Gut. 1999. PMID: 10486374 Free PMC article.

5

Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to the synthesis of a short core protein product.

Yeh CT, Lo SY, Dai DI, Tang JH, Chu CM, Liaw YF. Yeh CT, et al. Among authors: liaw yf. J Gastroenterol Hepatol. 2000 Feb;15(2):182-91. doi: 10.1046/j.1440-1746.2000.02066.x. J Gastroenterol Hepatol. 2000. PMID: 10735543

6

Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy.

Yeh CT, Chien RN, Chu CM, Liaw YF. Yeh CT, et al. Among authors: liaw yf. Hepatology. 2000 Jun;31(6):1318-26. doi: 10.1053/jhep.2000.7296. Hepatology. 2000. PMID: 10827158

7

Olone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant.

Yeh CT, Sheen IS, Chen TC, Hsieh SY, Chu CM, Liaw YF. Yeh CT, et al. Among authors: liaw yf. J Hepatol. 2000 May;32(5):829-36. doi: 10.1016/s0168-8278(00)80253-6. J Hepatol. 2000. PMID: 10845671 Clinical Trial.

8

Reactivation of hepatitis C virus superinfection in a patient seropositive for hepatitis B e antigen.

Chen LW, Yeh CT, Fang KM, Chu CM, Liaw YF. Chen LW, et al. Among authors: liaw yf. Infection. 2001 Dec;29(6):351-4. doi: 10.1007/s15010-001-1195-6. Infection. 2001. PMID: 11787840

9

Increased incidence of fulminant hepatic failure in previously unrecognized HBsAg carriers with acute hepatitis independent of etiology.

Chu CM, Liaw YF. Chu CM, et al. Among authors: liaw yf. Infection. 2005 Jun;33(3):136-9. doi: 10.1007/s15010-005-4094-4. Infection. 2005. PMID: 15940414

10

Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection.

Sheen IS, Liaw YF, Chu CM, Pao CC. Sheen IS, et al. Among authors: liaw yf. J Infect Dis. 1992 May;165(5):831-4. doi: 10.1093/infdis/165.5.831. J Infect Dis. 1992. PMID: 1314869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters